ATE171372T1 - Verwendung eines antagonisten der substanz p zur behandlung von hautrötungen neurogen ursprungs - Google Patents
Verwendung eines antagonisten der substanz p zur behandlung von hautrötungen neurogen ursprungsInfo
- Publication number
- ATE171372T1 ATE171372T1 AT95402582T AT95402582T ATE171372T1 AT E171372 T1 ATE171372 T1 AT E171372T1 AT 95402582 T AT95402582 T AT 95402582T AT 95402582 T AT95402582 T AT 95402582T AT E171372 T1 ATE171372 T1 AT E171372T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonist
- substance
- treatment
- skin redness
- neurogenic origin
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 230000001272 neurogenic effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9415252A FR2728165A1 (fr) | 1994-12-19 | 1994-12-19 | Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE171372T1 true ATE171372T1 (de) | 1998-10-15 |
Family
ID=9469930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95402582T ATE171372T1 (de) | 1994-12-19 | 1995-11-17 | Verwendung eines antagonisten der substanz p zur behandlung von hautrötungen neurogen ursprungs |
Country Status (15)
Country | Link |
---|---|
US (1) | US5744156A (de) |
EP (1) | EP0722722B2 (de) |
JP (1) | JPH08208508A (de) |
AR (1) | AR000357A1 (de) |
AT (1) | ATE171372T1 (de) |
BR (1) | BR9505381A (de) |
CA (1) | CA2165518C (de) |
DE (1) | DE69504949T3 (de) |
DK (1) | DK0722722T4 (de) |
ES (1) | ES2124983T5 (de) |
FR (1) | FR2728165A1 (de) |
HU (1) | HU218944B (de) |
MX (1) | MX9505192A (de) |
PL (1) | PL311917A1 (de) |
RU (1) | RU2140263C1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2732221B1 (fr) * | 1995-03-28 | 1997-04-25 | Oreal | Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue |
FR2738742B1 (fr) * | 1995-09-19 | 1997-11-14 | Oreal | Utilisation d'au moins une eau thermale de vichy en tant qu'antagoniste de substance p |
US7419683B2 (en) * | 1997-10-31 | 2008-09-02 | United States Of America As Represented By The Secretary Of The Army | Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
FR2774285B1 (fr) | 1998-02-03 | 2001-06-15 | Roche Posay Lab Pharma | Utilisation d'une composition cosmetique pour le traitement et la prevention de la rosacee |
US5972993A (en) * | 1998-03-20 | 1999-10-26 | Avon Products, Inc. | Composition and method for treating rosacea and sensitive skin with free radical scavengers |
TW537894B (en) * | 1998-05-26 | 2003-06-21 | Novartis Ag | A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist |
DE10025553A1 (de) * | 2000-05-24 | 2001-11-29 | Merck Patent Gmbh | Zusammensetzung, enthaltend mindestens ein Aryloxim und mindestens einen Wirkstoff zur Behandlung von Akne und ihre Verwendung |
WO2003037334A1 (en) * | 2001-10-31 | 2003-05-08 | Merck & Co., Inc. | Method for treating or preventing symptoms of hormonal variation including hot flashes |
US20060263350A1 (en) * | 2003-09-26 | 2006-11-23 | Fairfield Clinical Trials Llc | Combination antihistamine medication |
EP1600158A1 (de) * | 2004-05-26 | 2005-11-30 | Galderma Research & Development, S.N.C. | Verwendung von Ondansetron zur Behandlung von Entzündungen und Arzneimittel, die es enthalten |
FR2866566A1 (fr) * | 2004-02-20 | 2005-08-26 | Galderma Res & Dev | Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee |
US20070154448A1 (en) | 2005-11-22 | 2007-07-05 | Ted Reid | Methods and compositions using Substance P to promote wound healing |
US20110052697A1 (en) * | 2006-05-17 | 2011-03-03 | Gwangju Institute Of Science & Technology | Aptamer-Directed Drug Delivery |
CN101600724B (zh) | 2006-10-16 | 2013-03-13 | 狮王株式会社 | Nk1受体拮抗剂组合物 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5921656A (ja) | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | ポリペプチド誘導体 |
US4472305A (en) | 1983-05-17 | 1984-09-18 | Sterling Drug Inc. | Hexapeptide amides |
US4839465A (en) | 1987-01-20 | 1989-06-13 | Sterling Drug Inc. | Di-(D-tryptophyl and/or tetrahydropyridoindolylcarbonyl)-containing peptide amides and process for preparation thereof |
GB8807921D0 (en) | 1988-04-05 | 1988-05-05 | Fujisawa Pharmaceutical Co | Ws-9326 & its derivatives |
US5187156A (en) | 1988-03-16 | 1993-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
GB8807246D0 (en) | 1988-03-25 | 1988-04-27 | Merck Sharp & Dohme | Therapeutic agents |
EP0360390A1 (de) † | 1988-07-25 | 1990-03-28 | Glaxo Group Limited | Spirolactamderivate |
WO1990005525A1 (en) | 1988-11-23 | 1990-05-31 | Pfizer Inc. | Quinuclidine derivatives as substance p antagonists |
US5164372A (en) | 1989-04-28 | 1992-11-17 | Fujisawa Pharmaceutical Company, Ltd. | Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same |
FR2654726B1 (fr) | 1989-11-23 | 1992-02-14 | Rhone Poulenc Sante | Nouveaux derives de l'isoindolone et leur preparation. |
FR2654725B1 (fr) | 1989-11-23 | 1992-02-14 | Rhone Poulenc Sante | Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent. |
GB8929070D0 (en) | 1989-12-22 | 1990-02-28 | Fujisawa Pharmaceutical Co | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same |
US5232929A (en) | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
WO1991009844A1 (en) | 1990-01-04 | 1991-07-11 | Pfizer Inc. | Substance p antagonists |
EP0515681A4 (en) | 1990-02-15 | 1993-12-29 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compound |
HU226529B1 (en) | 1990-05-31 | 2009-03-30 | Pfizer | Process for preparing substituted piperidines |
AU648317B2 (en) | 1990-06-01 | 1994-04-21 | Pfizer Inc. | 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them |
ATE129409T1 (de) | 1990-12-21 | 1995-11-15 | Fujisawa Pharmaceutical Co | Neue verwendung von peptidderivat. |
EP0566589A1 (de) | 1991-01-10 | 1993-10-27 | Pfizer Inc. | N-alkyl chinuclidiniumsalze als substanz-p-antagoniste |
ATE154354T1 (de) | 1991-02-11 | 1997-06-15 | Merck Sharp & Dohme | Azabicyclische verbindungen, diese enthaltende pharmazeutische zubereitungen und ihre therapeutische verwendung |
ES2065175T3 (es) | 1991-03-01 | 1995-02-01 | Pfizer | Derivados de 1-azabiciclo(3.2.2)nonan-3-amina. |
CA2106200C (en) | 1991-03-26 | 1996-11-19 | Terry J. Rosen | Stereoselective preparation of substituted piperidines |
FR2677361A1 (fr) | 1991-06-04 | 1992-12-11 | Adir | Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2676447B1 (fr) | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux derives du thiopyranopyrrole et leur preparation. |
FR2676446B1 (fr) | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent. |
FR2676442B1 (fr) | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent. |
FR2676443B1 (fr) | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux derives de perhydroisoindole et leur preparation. |
PL170513B1 (en) | 1991-05-22 | 1996-12-31 | Pfizer | Method of obtaining novel derivatives of 3-amino quinuclidine |
GB9113219D0 (en) | 1991-06-19 | 1991-08-07 | Fujisawa Pharmaceutical Co | Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same |
ATE142199T1 (de) | 1991-06-20 | 1996-09-15 | Pfizer | Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen |
TW202432B (de) | 1991-06-21 | 1993-03-21 | Pfizer | |
US5288730A (en) † | 1991-06-24 | 1994-02-22 | Merck Sharp & Dohme Limited | Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
WO1993001169A2 (en) | 1991-07-05 | 1993-01-21 | Merck Sharp & Dohme Limited | Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
ATE133657T1 (de) † | 1991-07-05 | 1996-02-15 | Merck Sharp & Dohme | Aromatische verbindungen, diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische anwendung |
US5495047A (en) † | 1991-07-10 | 1996-02-27 | Merck, Sharp & Dohme (Ltd.) | Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy |
MY110227A (en) | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
US5459270A (en) | 1991-08-20 | 1995-10-17 | Merck Sharp & Dohme Limited | Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
IL99368A (en) * | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
HU9400728D0 (en) | 1991-09-26 | 1994-06-28 | Pfizer | Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists |
WO1993009116A1 (en) | 1991-11-07 | 1993-05-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Quinuclidine compound and medicinal use thereof |
CA2083891A1 (en) | 1991-12-03 | 1993-06-04 | Angus Murray Macleod | Heterocyclic compounds, compositions containing them and their use in therapy |
GB9201179D0 (en) † | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
JPH05339240A (ja) * | 1992-06-04 | 1993-12-21 | Yamanouchi Pharmaceut Co Ltd | テトラヒドロイソキノリンアミド誘導体 |
IL106142A (en) * | 1992-06-29 | 1997-03-18 | Merck & Co Inc | Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them |
GB9222486D0 (en) † | 1992-10-26 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
FR2719474B1 (fr) † | 1994-05-05 | 1996-05-31 | Oreal | Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue. |
-
1994
- 1994-12-19 FR FR9415252A patent/FR2728165A1/fr active Granted
-
1995
- 1995-11-17 AT AT95402582T patent/ATE171372T1/de not_active IP Right Cessation
- 1995-11-17 DK DK95402582T patent/DK0722722T4/da active
- 1995-11-17 DE DE69504949T patent/DE69504949T3/de not_active Expired - Lifetime
- 1995-11-17 ES ES95402582T patent/ES2124983T5/es not_active Expired - Lifetime
- 1995-11-17 EP EP95402582A patent/EP0722722B2/de not_active Expired - Lifetime
- 1995-12-08 BR BR9505381A patent/BR9505381A/pt active Search and Examination
- 1995-12-11 MX MX9505192A patent/MX9505192A/es unknown
- 1995-12-15 AR AR33463595A patent/AR000357A1/es not_active Application Discontinuation
- 1995-12-18 CA CA002165518A patent/CA2165518C/fr not_active Expired - Lifetime
- 1995-12-18 RU RU95121082A patent/RU2140263C1/ru active
- 1995-12-18 HU HU9503625A patent/HU218944B/hu not_active IP Right Cessation
- 1995-12-18 PL PL95311917A patent/PL311917A1/xx unknown
- 1995-12-18 JP JP7329300A patent/JPH08208508A/ja active Pending
- 1995-12-19 US US08/574,856 patent/US5744156A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69504949T3 (de) | 2004-01-15 |
BR9505381A (pt) | 1997-11-18 |
ES2124983T5 (es) | 2003-11-16 |
DE69504949T2 (de) | 1999-02-18 |
HU9503625D0 (en) | 1996-02-28 |
DK0722722T3 (da) | 1999-06-14 |
CA2165518A1 (fr) | 1996-06-20 |
HUT74948A (en) | 1997-03-28 |
MX9505192A (es) | 1997-04-30 |
FR2728165A1 (fr) | 1996-06-21 |
EP0722722A1 (de) | 1996-07-24 |
CA2165518C (fr) | 2002-07-16 |
EP0722722B2 (de) | 2003-03-05 |
JPH08208508A (ja) | 1996-08-13 |
ES2124983T3 (es) | 1999-02-16 |
US5744156A (en) | 1998-04-28 |
HU218944B (hu) | 2001-01-29 |
EP0722722B1 (de) | 1998-09-23 |
FR2728165B1 (de) | 1997-02-07 |
DK0722722T4 (da) | 2003-07-07 |
DE69504949D1 (de) | 1998-10-29 |
RU2140263C1 (ru) | 1999-10-27 |
AR000357A1 (es) | 1997-06-18 |
PL311917A1 (en) | 1996-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE214274T1 (de) | Antikonvulsiva zur verwendung bei der behandlung von amyotropischer lateralsklerose | |
DE4391418T1 (de) | Vorrichtung zur elektrochemischen Behandlung von Wasser | |
DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
DE69504949D1 (de) | Verwendung eines Antagonisten der Substanz P zur Behandlung von Hautrötungen neurogen Ursprungs | |
ATE179610T1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
DE69307509D1 (de) | Vorrichtung zur behandlung von herzfehlern | |
DE69528475D1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
DE69838338D1 (de) | Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
DE69934877D1 (de) | Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen | |
DE69827126D1 (de) | Verwendung von hypothalamus-hemmfaktor zur behandlung von ischämischen herzstörungen | |
DE69634951D1 (de) | Topische verwendung von betulinsäure zur behandlung bösartiger melanome | |
ATE173620T1 (de) | Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs | |
DE59707519D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
DE69912670D1 (de) | Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen | |
DE69939723D1 (de) | Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie | |
DE50011325D1 (de) | Vorrichtung zur Erkennung der Kreislaufwirkungen von Extrasystolen | |
DE69829217D1 (de) | Vorrichtung zur therapeutischen behandlung von blutgefässen | |
DE69621447D1 (de) | Verwendung von nitroflavonoide zur behandlung von angstzuständen | |
DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
DE69701458D1 (de) | Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen | |
DE69404725D1 (de) | Verfahren zur elektrolytischen Behandlung von Altbatterien |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |